Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications

Am J Hematol. 2012 Jul;87(7):684-6. doi: 10.1002/ajh.23230. Epub 2012 May 6.

Abstract

Among 6,565 consecutive abnormal cytogenetic reports at our institution, 3,192 (49%) constituted sole abnormalities, of which 230 (7%) involved chromosome 7: monosomy 7 (n = 98), 7q- (n = 51), der(1;7)(q10;p10) (n = 44), balanced translocations (n = 15), ring 7 (n = 13), and 7p- (n = 9). The most frequent histopathologic correlates were myelodysplastic syndromes (MDS; 28%), acute myeloid leukemia (AML; 17%), secondary or therapy-related MDS/AML (13%), primary myelofibrosis (PMF; 7%), and chronic myelomonocytic leukemia (6%). Monosomy 7 was the most frequent in each one of these disease categories except PMF where 7q- was more frequent. In primary MDS, patients with der(1;7)(q10;p10) (n = 13), compared to those with monosomy 7 (n = 30) or 7q- (n = 15), were less likely (P = 0.04) to display excess blasts or multilineage dysplasia but overall and leukemia-free survival adjusted for these variables revealed no significant difference between the three groups (P = 0.57 and 0.81, respectively). The current study does not prognostically distinguish monosomy 7 from 7q- or der(1;7), in MDS.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects
  • Chromosome Aberrations*
  • Chromosomes, Human, Pair 7 / genetics*
  • Cohort Studies
  • Female
  • Genetic Association Studies
  • Humans
  • Leukemia, Myeloid / chemically induced
  • Leukemia, Myeloid / genetics*
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / chemically induced
  • Myelodysplastic Syndromes / genetics*
  • Myeloproliferative Disorders / chemically induced
  • Myeloproliferative Disorders / genetics*
  • Primary Myelofibrosis / genetics
  • Ring Chromosomes
  • Survival Analysis
  • Translocation, Genetic
  • United States
  • Young Adult

Substances

  • Antineoplastic Agents